These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 1666519)

  • 1. [Relationship of antioxidant and anti-ischemic effects of various energy-yielding compounds].
    Sergeev PV; Snegireva GV; Gukasov VM; Gatsura VV
    Biull Eksp Biol Med; 1991 Oct; 112(10):381-2. PubMed ID: 1666519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The characteristics of the cardioprotective action of fructose-1,6-diphosphate].
    Sernov LN; Rozonov IuB; Sokolova OA; Shal'neva TV; Snegireva GV; Gatsura VV
    Biull Eksp Biol Med; 1991 Feb; 111(2):172-3. PubMed ID: 1854962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of fructose-1,6-diphosphate, cytochrome c and their combination on the size of the necrotic area in transient myocardial ischemia].
    Imatdieva RM; Gatsura VV
    Eksp Klin Farmakol; 1997; 60(1):32-4. PubMed ID: 9162279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of metabolic agents on the antiarrhythmic activity of novocainamide and acetylnovocainamide].
    Beregovaia EG; Gorchakova NA; Samarskaia TG; Dunaev VV; Chekman IS
    Farmakol Toksikol; 1990; 53(5):34-7. PubMed ID: 1701394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of Krebs cycle intermediates on the size of the necrotic zone and on the course of early postocclusion arrhythmia in experimental myocardial infarct in rats].
    Sernov LN; Snegireva GV; Gatsura VV
    Farmakol Toksikol; 1989; 52(6):47-9. PubMed ID: 2625147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of fructose-1,6-diphosphate on the size of the necrotic area and course of the acute period of experimental myocardial infarction in rats].
    Sernov LN; Snegireva GV; Gatsura VV
    Kardiologiia; 1989 Aug; 29(8):66-9. PubMed ID: 2585964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of cytoflavin for correction of complications of myocardial infarction].
    Bul'on VV; Khnychenko LK; Sapronov NS; Kovalenko AL; Alekseeva LE
    Eksp Klin Farmakol; 2002; 65(1):27-9. PubMed ID: 12025779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of ADP, malate and succinate on the electroretinogram of the isolated frog retina].
    Czepita D
    Klin Oczna; 1984 Mar; 86(3):113-5. PubMed ID: 6611447
    [No Abstract]   [Full Text] [Related]  

  • 9. [The effect of succinate combined with cytochrome C on postischemic disorders in the skeletal muscle of the extremities].
    Kostnikova IV; Ovchinnikov IV
    Eksp Klin Farmakol; 1995; 58(2):42-3. PubMed ID: 7773089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of sodium succinate and sodium malate on the composition of metabolites of tricarboxylic acid cycle and oxidative phosphorylation in the lungs of animals with bronchial asthma].
    Maliuk VI; Popova EM; Sokirko TA; Tumanova TA
    Probl Tuberk; 1987; (12):60-3. PubMed ID: 3444830
    [No Abstract]   [Full Text] [Related]  

  • 11. [The antiacidotic and cardioprotective effects of fructose-1,6-diphosphate and dehydroascorbic acid].
    Sernov LN; Sokolova OA; Gatsura VV
    Farmakol Toksikol; 1991; 54(4):24-6. PubMed ID: 1786815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A preclinical evaluation of the antianginal activity of energy metabolism intermediates].
    Kostin VI
    Farmakol Toksikol; 1989; 52(6):49-52. PubMed ID: 2560436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A comparative evaluation of the cardioprotective and antianginal actions of energy-providing agents].
    Sernov LN; Rozonov IuB; Gatsura VV
    Eksp Klin Farmakol; 1992; 55(4):13-5. PubMed ID: 1458176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inability of fructose 1,6-diphosphate to reduce myocardial infarct size.
    Brown EJ; Erburu L; Kloner RA
    J Med; 1987; 18(1):43-53. PubMed ID: 3474341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of malate, succinate and bicarbonate salts in preventing experimental oxalate urolithiasis in rats].
    Yamaguchi K; Ogawa Y; Morozumi M; Tanaka T; Kitagawa R
    Nihon Hinyokika Gakkai Zasshi; 1987 Feb; 78(2):311-8. PubMed ID: 3613335
    [No Abstract]   [Full Text] [Related]  

  • 16. Protective effects of exogenously administered fructose-1,6-diphosphate from ischemia reperfusion damage induced on isolated rat heart.
    Lazzarino G; Tavazzi B; Nuutinen M; Giardina B
    Ital J Biochem; 1989; 38(4):251A-253A. PubMed ID: 2583971
    [No Abstract]   [Full Text] [Related]  

  • 17. [Intracellular mechanisms of the effect of cytochrome C on various areas of the myocardium during the dynamic development of an experimental infarct].
    Irgashev ShB; Iuldashev NM
    Farmakol Toksikol; 1988; 51(5):41-4. PubMed ID: 2850220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebral resuscitation with succinate and fructose-1, 6-diphosphate.
    Cannella DM; Kapp JP; Munschauer FE; Markov AK; Shucard DW
    Surg Neurol; 1989 Mar; 31(3):177-82. PubMed ID: 2922659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Close association between the reduction in myocardial energy metabolism and infarct size: dose-response assessment of cyclosporine.
    Niemann CU; Saeed M; Akbari H; Jacobsen W; Benet LZ; Christians U; Serkova N
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1123-8. PubMed ID: 12183671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of sodium succinate in patients with a history of myocardial infarction].
    Aktaeva IN; Gulyĭ VIa; Likhtenshteĭn IE; Maliuk VI; Bugaenko VV
    Vrach Delo; 1985 Jun; (6):6-8. PubMed ID: 4024588
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.